Location · Akron, OH
Clinical trials in Akron, OH
24 recruiting studies have a site in Akron, and 2 of them accept healthy volunteers.
24 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteers
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Qurasense
- Location
- Akron, OH + 2 other US sites
- Eligibility basics
- Ages 25+ · Women only
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Akron, OH + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
H. Lundbeck A/S
- Location
- Akron, OH + 13 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
H. Lundbeck A/S
- Location
- Akron, OH + 8 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Boehringer Ingelheim
- Location
- Akron, OH + 9 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
Vericel Corporation
- Location
- Akron, OH + 10 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 2
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated…
Eccogene
- Location
- Akron, OH + 65 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc.
- Location
- Akron, OH + 44 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
The PERSEVERE Study
Inari Medical
- Location
- Akron, OH + 15 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Anagram Therapeutics, Inc.
- Location
- Akron, OH + 19 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
INHANCE Stemless Reverse Shoulder IDE
DePuy Orthopaedics
- Location
- Akron, OH + 13 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Akron, OH + 46 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Open Label Extension to Assess Long Term Safety and Efficacy of KL1333 in Patients With Primary Mitochondrial Disease
Pharming Technologies B.V.
- Location
- Akron, OH
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
DiaMedica Therapeutics Inc
- Location
- Akron, OH + 35 other US sites
- Eligibility basics
- Ages 18–90
- Recruiting
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Kaneka Medical America LLC
- Location
- Akron, OH + 9 other US sites
- Eligibility basics
- Up to age 21
- Recruiting
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
Kaneka Medical America LLC
- Location
- Akron, OH + 9 other US sites
- Eligibility basics
- Up to age 75
- RecruitingPhase 2
Study of DONQ52 in Active Celiac Disease
Chugai Pharmaceutical
- Location
- Akron, OH + 57 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Pro-2-Cool Pivotal Trial II
TecTraum Inc.
- Location
- Akron, OH
- Eligibility basics
- Ages 13–21
- RecruitingPhase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Akron, OH + 62 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Pharming Technologies B.V.
- Location
- Akron, OH + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
AMAG Pharmaceuticals, Inc.
- Location
- Akron, OH + 3 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
Medicure
- Location
- Akron, OH + 4 other US sites
- Eligibility basics
- Any age listed
- Recruiting
VasoStar Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions
VasoStar, LLC
- Location
- Akron, OH + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Columbia University
- Location
- Akron, OH + 15 other US sites
- Eligibility basics
- Any age listed